Doctors Warn of Pradaxa Internal Bleeding Injuries

A number of families have lost loved ones because there is no internal bleeding antidote and have filed wrongful death Pradaxa lawsuits as a result of their loss. It has been reported that the manufacturers of Pradaxa have made more than $1 billion from the medication since its release onto the market in 2010. It has been the claim in a number of the Pradaxa lawsuits that the drug should have never been released onto the market without the antidote in place and because of the company’s greed their loved ones have paid the ultimate price.

FDA Investigates Pradaxa Side Effects

By December 7, 2011, the FDA warned that they were investigating injuries resulting from Pradaxa side effects. According to a statement released by USA today as of August 19, 2012, “3,781 side effects and 542 deaths were reported among users in 2011, which led all other medications.” The numbers are quite alarming and although many anticoagulant medications coincide with internal bleeding risks, as mentioned above, there are typically working antidotes available to use, which was not the case with Pradaxa making the drug far more dangerous than any other drug in its class.

Manufacturers Claim They Were Unaware of Pradaxa Bleeding Risks

The manufacturers claim they were unaware of that fact that any of the traditional antidotes did not work for Pradaxa users and yet too much evidence has mounted against that statement to suggest otherwise. In lieu of that evidence, the company faces several Pradaxa internal bleeding lawsuits, which may result in heavy legal costs in association to the injuries and deaths incurred by users of the medication.

It is suggested that the manufacturers of Pradaxa knew bleeding antidotes would not work with Pradaxa since they released a statement that it was safe to consumer Vitamin K while using this medication. Vitamin K is a common bleeding antidote used with medications similar to Pradaxa. If the manufacturers stated that it was safe to consume Vitamin K while using Pradaxa, they must have known that it would not work as an antidote, thus suggesting the manufacturers knew better.

In an effort to reverse the negative internal bleeding side effects associated with Pradaxa, it was reported that the manufacturers are finally working on an antidote but for many Pradaxa victims this is occurring too little, too late. Doctors continue to warn about the bleeding injuries associated with the use of Pradaxa. Additionally, a report released by the Institute for Safe Medicine Practices’ Quarter Watch stated that “prescription drug complaints to the FDA have risen 90% in the past 4 years, and two drugs, Pradaxa and Chantix, are responsible for 37% of that increase.”

Pradaxa Lawsuit MDL

Although Pradaxa has only been on the market for a short time, there have been so many Pradaxa lawsuits filed that a Pradaxa lawsuit multidistrict litigation (MDL) has been established. It is referred to as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. The Honorable Judge David Herndon is overseeing the Pradaxa lawsuit MDL. It has been indicated that the trials will begin within the next two years.